Kodiak Sciences (KOD) Other Working Capital Changes (2019 - 2026)
Kodiak Sciences (KOD) posted Other Working Capital Changes of -$3.2 million for Q1 2026, down 5.53% on a QoQ basis from -$3.0 million in Q4 2025, and down 17.81% year-over-year from -$3.9 million in Q1 2025.
Kodiak Sciences (KOD) Other Working Capital Changes (2019 - 2026) Analysis & Trends
Kodiak Sciences' Other Working Capital Changes history runs 8 years deep, the most recent figure standing at -$3.2 million for Q1 2026.
- Quarterly Other Working Capital Changes fell 17.81% year-over-year to -$3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$11.6 million (down 9.04% YoY) and the FY2025 annual result came in at -$11.2 million, up 0.76% from the prior year.
- Other Working Capital Changes was -$3.2 million for Q1 2026 at Kodiak Sciences, down from -$3.0 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $7.2 million in Q1 2022 and bottomed at -$17.4 million in Q2 2022.
- A 5-year average of -$403000.0 and a median of -$44000.0 in 2025 frame the typical range for Other Working Capital Changes.
- Peak annual rise in Other Working Capital Changes reached 7403.09% in 2023, while the deepest fall reached 340.0% in 2023.
- Kodiak Sciences' Other Working Capital Changes stood at -$97000.0 in 2022, then soared by 7403.09% to $7.1 million in 2023, then tumbled by 143.62% to -$3.1 million in 2024, then advanced by 2.23% to -$3.0 million in 2025, then fell by 5.53% to -$3.2 million in 2026.
- Business Quant data shows KOD's Other Working Capital Changes at -$3.2 million in Q1 2026, -$3.0 million in Q4 2025, and -$3.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Kodiak Sciences | 2.54 Bn | 2.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.19 Mn |
| Mar 31, 2026 | -3.19 Mn |
| Mar 31, 2026 | -3.19 Mn |
| Dec 31, 2025 | -3.02 Mn |
| Dec 31, 2025 | -3.02 Mn |
| Dec 31, 2025 | -3.02 Mn |
| Sep 30, 2025 | -3.01 Mn |
| Sep 30, 2025 | -3.01 Mn |
| Sep 30, 2025 | -3.01 Mn |
| Jun 30, 2025 | -2.43 Mn |
| Jun 30, 2025 | -2.43 Mn |
| Jun 30, 2025 | -2.43 Mn |
| Mar 31, 2025 | -2.71 Mn |
| Mar 31, 2025 | -2.71 Mn |
| Mar 31, 2025 | -2.71 Mn |
| Dec 31, 2024 | -3.09 Mn |
| Dec 31, 2024 | -3.09 Mn |
| Dec 31, 2024 | -3.09 Mn |
| Sep 30, 2024 | -2.32 Mn |
| Sep 30, 2024 | -2.32 Mn |